CFAP45 and non-small cell lung carcinoma: Similar to our previous reports, CCDC19 not only significantly inhibited the proliferation and G1/S cell cycle transition of NSCLC cells in vitro but also markedly suppressed tumourigenicity in an in vivo xenograft animal model.